Literature DB >> 7526483

Circulating endothelial cell/leukocyte adhesion molecules in atherosclerosis.

A D Blann1, C N McCollum.   

Abstract

Soluble adhesion molecules E-selectin, intercellular adhesion molecule (sICAM) and vascular cell adhesion molecule (sVCAM) were measured alongside von Willebrand factor (vWf) in 40 patients with peripheral vascular disease (PVD), 43 with ischaemic heart disease (IHD) and in equal numbers of age and sex matched asymptomatic controls. Increased vWf was found in patients with IHD (p = 0.0008) and in patients with PVD (p = 0.0001) relative to their respective controls but levels did not differ between the two patient groups. Raised sICAM was found in both PVD (p = 0.0003) and IHD (p = 0.0059) compared to their respective controls and was higher in PVD than in IHD (p = 0.0088). In the subjects taken as a whole, there was no correlation between vWf and sICAM. Levels of soluble E-selectin and sVCAM did not differ in patients or controls. These data suggest that soluble ICAM may be useful as an index of endothelial cell activation in clinical manifestations of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7526483

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  23 in total

1.  Soluble E-selectin is not a marker of unstable coronary plaque in serum of patients with ischemic heart disease.

Authors:  M Galvani; D Ferrini; F Ottani; C Nanni; A Ramberti; P Amboni; L Iamele; A Vernocchi; F A Nicolini
Journal:  J Thromb Thrombolysis       Date:  2000-01       Impact factor: 2.300

2.  Postpartum development of endothelial dysfunction and oxidative stress markers in women with previous gestational diabetes mellitus.

Authors:  M M Roca-Rodríguez; C López-Tinoco; M Murri; A Fernández-Deudero; M V García-Palacios; M A García-Valero; F J Tinahones-Madueño; M Aguilar-Diosdado
Journal:  J Endocrinol Invest       Date:  2014-01-24       Impact factor: 4.256

3.  Elevated circulating adhesion molecules in NIDDM--potential mediators in diabetic macroangiopathy.

Authors:  P Fasching; W Waldhäusl; O F Wagner
Journal:  Diabetologia       Date:  1996-10       Impact factor: 10.122

Review 4.  Markers of tumor angiogenesis: clinical applications in prognosis and anti-angiogenic therapy.

Authors:  S B Fox; A L Harris
Journal:  Invest New Drugs       Date:  1997       Impact factor: 3.850

5.  Increased release of the soluble form of the adhesion molecules L-selectin and ICAM-1 but not E-selectin during attacks of angina pectoris.

Authors:  T Siminiak; J Smielecki; J F Dye; M Baliñski; H El-Gendi; H Wysocki; D J Sheridan
Journal:  Heart Vessels       Date:  1998       Impact factor: 2.037

6.  Effects of angiotensin II-receptor blockers on soluble cell adhesion molecule levels in uncomplicated systemic hypertension: An observational, controlled pilot study in Taiwanese adults.

Authors:  Yeo-Shin Hwang; Wen-Chan Tsai; Ye-Hsu Lu; Ching-Cheng Lin; Kun-Yen Tsai
Journal:  Curr Ther Res Clin Exp       Date:  2005-05

7.  Prognostic value of serum von Willebrand factor, but not soluble ICAM and VCAM, for mortality and cardiovascular events is independent of residual renal function in peritoneal dialysis patients.

Authors:  Jie Dong; Yan-Jun Li; Zhi-Kai Yang; Rong Xu
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

8.  Thrombolytic therapy with urokinase reduces increased circulating endothelial adhesion molecules in acute myocardial infarction.

Authors:  F Squadrito; A Saitta; D Altavilla; M Ioculano; P Canale; G M Campo; G Squadrito; G Di Tano; A Mazzu; A P Caputi
Journal:  Inflamm Res       Date:  1996-01       Impact factor: 4.575

9.  Hypoxia and antioxidants enhance soluble ICAM-1 release from cardiac fibroblasts.

Authors:  S Sapna; K Shivakumar
Journal:  Mol Cell Biochem       Date:  2007-04-26       Impact factor: 3.396

10.  Inflammatory cytokines, endothelial markers and adhesion molecules in rheumatoid arthritis: effect of intensive anti-inflammatory treatment.

Authors:  Will Foster; David Carruthers; Gregory Y H Lip; Andrew D Blann
Journal:  J Thromb Thrombolysis       Date:  2010-05       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.